Logo image of RDNT

RADNET INC (RDNT) Stock Price, Quote, News and Overview

NASDAQ:RDNT - Nasdaq - US7504911022 - Common Stock - Currency: USD

63.45  -0.63 (-0.98%)

RDNT Quote, Performance and Key Statistics

RADNET INC

NASDAQ:RDNT (1/27/2025, 11:40:39 AM)

63.45

-0.63 (-0.98%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High93.65
52 Week Low35.16
Market Cap4.70B
Shares74.03M
Float66.04M
Yearly DividendN/A
Dividend YieldN/A
PE113.3
Fwd PE84.06
Earnings (Next)N/A N/A
IPO12-12 2001-12-12


RDNT short term performance overview.The bars show the price performance of RDNT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10

RDNT long term performance overview.The bars show the price performance of RDNT in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200

The current stock price of RDNT is 63.45 USD. In the past month the price decreased by -11.76%. In the past year, price increased by 71.98%.

RADNET INC / RDNT Daily stock chart

RDNT Latest News, Press Releases and Analysis

News Image
19 days ago - RadNet, Inc.

RadNet, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference January 15th, 2025

LOS ANGELES, Jan. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic...

News Image
a month ago - Investor's Business Daily

DaVita Stock Sees Improved Relative Strength Rating

DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.

News Image
a month ago - FinancialNewsMedia

The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care

USA News Group  Commentary Issued on behalf of Avant Technologies Inc.   Vancouver, BC – December 17, 2024  – USA News Group News Commentary – Artificial intelligence (AI) is on the brink of becoming a critical resource in healthcare, moving beyond its status as a novel concept. With over 800 FDA-cleared AI applications already in […]

News Image
2 months ago - Ketryx

Ketryx Announces DeepHealth Selected Its Software to Accelerate AI-Powered Health Informatics Innovation

/PRNewswire/ -- Ketryx announced today that DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc....

RDNT Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
CI THE CIGNA GROUP 10.92 83.49B
CVS CVS HEALTH CORP 8.79 70.24B
LH LABCORP HOLDINGS INC 17.33 20.90B
DGX QUEST DIAGNOSTICS INC 17.99 17.75B
FMS FRESENIUS MEDICAL CARE-ADR 14.57 14.45B
DVA DAVITA INC 19.71 14.35B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 173.87 14.23B
CHE CHEMED CORP 24.84 8.52B
HIMS HIMS & HERS HEALTH INC 69.86 6.72B
CRVL CORVEL CORP 24.56 5.94B
GH GUARDANT HEALTH INC N/A 5.80B
OPCH OPTION CARE HEALTH INC 26.22 5.31B

About RDNT

Company Profile

RDNT logo image RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 7,872 full-time employees. The company went IPO on 2001-12-12. The company has a network of 366 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.

Company Info

RADNET INC

1510 Cotner Ave

Los Angeles CALIFORNIA 90025 US

CEO: Howard G. Berger

Employees: 7872

Company Website: https://www.radnet.com/

Investor Relations: https://www.radnet.com/about-radnet/investor-relations

Phone: 13104787808

RDNT FAQ

What is the stock price of RDNT?

The current stock price of RDNT is 63.45 USD.


What is the symbol for RADNET INC stock?

The exchange symbol of RADNET INC is RDNT and it is listed on the Nasdaq exchange.


On which exchange is RDNT stock listed?

RDNT stock is listed on the Nasdaq exchange.


Is RDNT a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for RDNT, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of RDNT.


Does RDNT stock pay dividends?

RDNT does not pay a dividend.


What is the Price/Earnings (PE) ratio of RDNT?

The PE ratio for RDNT is 113.3. This is based on the reported non-GAAP earnings per share of 0.56 and the current share price of 63.45 USD.


What is the Short Interest ratio of RDNT stock?

The outstanding short interest for RDNT is 6.07% of its float.


RDNT Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to RDNT. When comparing the yearly performance of all stocks, RDNT is one of the better performing stocks in the market, outperforming 88.15% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

RDNT Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to RDNT. RDNT has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RDNT Financial Highlights

Over the last trailing twelve months RDNT reported a non-GAAP Earnings per Share(EPS) of 0.56. The EPS decreased by 36.59% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -0.13%
ROE -0.49%
Debt/Equity 1.11
Chartmill High Growth Momentum
EPS Q2Q%-7.14%
Sales Q2Q%14.72%
EPS 1Y (TTM)36.59%
Revenue 1Y (TTM)12.2%

RDNT Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 85% to RDNT. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of 33.96% and a revenue growth 13.31% for RDNT


Ownership
Inst Owners85.36%
Ins Owners11.96%
Short Float %6.07%
Short Ratio7.3
Analysts
Analysts85
Price Target91.97 (44.95%)
EPS Next Y33.96%
Revenue Next Year13.31%